Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity.
He Y, Zhang X, Chang J, Kim HN, Zhang P, Wang Y, Khan S, Liu X, Zhang X, Lv D, Song L, Li W, Thummuri D, Yuan Y, Wiegand JS, Ortiz YT, Budamagunta V, Elisseeff JH, Campisi J, Almeida M, Zheng G, Zhou D.
He Y, et al. Among authors: li w.
Nat Commun. 2020 Apr 24;11(1):1996. doi: 10.1038/s41467-020-15838-0.
Nat Commun. 2020.
PMID: 32332723
Free PMC article.